SAN
DIEGO, Sept. 26, 2022 /PRNewswire/ -- NuVasive,
Inc. (NASDAQ: NUVA), the leader in spine technology innovation,
focused on transforming spine surgery with minimally disruptive,
procedurally integrated solutions, today announced it will continue
its partnership with the Society for Minimally Invasive Spine
Surgery (SMISS) as a sponsor and will attend the SMISS Annual Forum
'22 held September 29 to October 1,
2022 in Las Vegas.
"SMISS and NuVasive share a common belief in the importance of
research and education to advance less invasive surgery,"
said Chris Barry, chief executive officer at NuVasive.
"With multiple approaches to enable patient-specific, optimized
surgical outcomes, it is important to select the right procedure,
create a patient-specific surgical plan, and utilize enabling
technologies for more intelligent surgery. We look forward to
showcasing our clinically backed X360 portfolio, enabled by
Pulse®, at SMISS."
Visit booth #201/203 for live demonstrations of Pulse and
conversations with NuVasive leadership around X360 and
thoracolumbar posterior procedural solutions. NuVasive will name
the Pioneer in Lateral Access Award recipient during the SOLAS
session on Thursday, September
29.
About NuVasive
NuVasive,
Inc. (NASDAQ: NUVA) is the leader in spine technology
innovation, with a mission to transform surgery, advance care, and
change lives. The Company's less-invasive, procedurally integrated
surgical solutions are designed to deliver reproducible and
clinically proven outcomes. The Company's comprehensive procedural
portfolio includes surgical access instruments, spinal implants,
fixation systems, biologics, software for surgical planning,
navigation and imaging solutions, magnetically adjustable implant
systems for spine and orthopedics, and intraoperative
neuromonitoring technology and service offerings. With more
than $1 billion in net sales, NuVasive operates
in more than 50 countries serving surgeons, hospitals, and
patients. For more information, please
visit www.nuvasive.com.
Forward-Looking
Statements
NuVasive cautions you that statements
included in this news release that are not a description of
historical facts are forward-looking statements that involve risks,
uncertainties, assumptions and other factors which, if they do not
materialize or prove correct, could
cause NuVasive's results to differ materially from
historical results or those expressed or implied by such
forward-looking statements. The potential risks and uncertainties
which contribute to the uncertain nature of these statements
include, among others, risks associated with acceptance of the
Company's surgical products and procedures by spine surgeons and
hospitals, development and acceptance of new products or product
enhancements, clinical and statistical verification of the benefits
achieved via the use of NuVasive's products, the
Company's ability to adequately manage inventory as it continues to
release new products, its ability to recruit and retain management
and key personnel, and the other risks and uncertainties described
in NuVasive's news releases and periodic filings with
the Securities and Exchange
Commission. NuVasive's public filings with
the Securities and Exchange Commission are available at
www.sec.gov. NuVasive assumes no obligation to update any
forward-looking statement to reflect events or circumstances
arising after the date on which it was made.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/nuvasive-to-sponsor-and-participate-at-society-for-minimally-invasive-spine-surgery-smiss-annual-forum-22-301632736.html
SOURCE NuVasive, Inc.